Veravas has a total of 51 patents globally, out of which 4 have been granted. Of these 51 patents, more than 86% patents are active. Japan is where Veravas has filed the maximum number of patents, followed by United States of America and Australia. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Veravas.
Veravas founded in 2017, Veravas is a clinical diagnostics company pioneering early detection of Alzheimer’s and other neurological diseases. Its proprietary VeraBIND™ technology enables accurate biomarker detection from complex sample types, supporting the development of advanced diagnostic tests. The VeraBIND Tau assay is a first-of-its-kind blood-based test that identifies pathological tau activity, aiding in Alzheimer’s diagnosis even in early cognitive stages.
Do read about some of the most popular patents of Veravas which have been covered by us in this article and also you can find Veravas patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Veravas patent portfolio.
How many patents does Veravas have?
Veravas has a total of 51 patents globally. These patents belong to 8 unique patent families. Out of 51 patents, 44 patents are active.
How Many Patents did Veravas File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Veravas Applications Filed | Veravas Patents Granted |
2025 | 1 | 2 |
2024 | 4 | 1 |
2023 | 2 | – |
2022 | 2 | – |
2021 | 18 | 1 |
2020 | 7 | – |
2019 | 16 | – |
2017 | 1 | – |
How many Veravas patents are Alive/Dead?
Worldwide Patents

How Many Patents did Veravas File in Different Countries?

Countries in which Veravas Filed Patents
Country | Patents |
Japan | 8 |
United States of America | 8 |
Australia | 6 |
Europe (EPO) | 5 |
Israel | 5 |
Canada | 5 |
Korea (South) | 4 |
India | 3 |
Where are Research Centres of Veravas Patents Located?
All Research centers of Veravas are in the United States of America.
10 Best Veravas Patents
US20210302416A1 is the most popular patent in the Veravas portfolio. It has received 9 citations so far from companies like PrognomIQ, Zhengzhou Fangxin Biotechnology & Seer Inc.
Below is the list of 10 most cited patents of Veravas:
Publication Number | Citation Count |
US20210302416A1 | 9 |
WO2020023899A1 | 8 |
WO2021207743A1 | 5 |
WO2022036330A1 | 4 |
US20210190768A1 | 2 |
WO2020264083A1 | 2 |
WO2024155854A1 | 1 |
US20230091170A1 | 1 |
KR1020230041651A | 1 |
US10948484B2 | 1 |
What Percentage of Veravas US Patent Applications were Granted?
Veravas (Excluding its subsidiaries) has filed 7 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100.0%.
Below are the key stats of Veravas patent prosecution at the USPTO.

Which Law Firms are managing US Patents for Veravas?
Law Firm | Total Applications | Success Rate |
K&L Gates Llp | 7 | 50.00% |
What are Veravas key innovation segments?
What Technologies are Covered by Veravas?

The chart below distributes patents filed by Veravas in different countries on the basis of the technology protected in patents. It also represents the markets where Veravas thinks it’s important to protect particular technological inventions.

R&D Focus: How has Veravas search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Veravas?